INCR InterCure Ltd.: Company Short-Term Debt

Corporate emblem and logo of InterCure (INCR)

InterCure Ltd. dominates the Israeli medical cannabis sector, generating steady revenue through its own pharmacy network. The company is scaling its European presence by optimizing internal costs. Growth is driven by global partnerships and the decriminalization trend. The amount of short-term financial debt helps assess the risk of cash flow gaps, with the 0.02 mark serving as a current indicator of current liabilities.

Canndoc (INCR) - Company Short-Term Loans and Borrowings from 07/04/2022 to 10/30/2026

Summary analytical data breakdowns for InterCure Ltd (INCR)

- stock price and consensus target price:
Stock Price Canndoc|INCR - Consensus Target
- company stock capitalization data:
Market Value InterCure Ltd.|INCR - Total Enterprise Value
- shareholders' equity book value data:
Accounting Value per Share InterCure|INCR - Accounting Value of Company|Market Capitalization to Book Value Ratio intercure.co|INCR - Total Asset Value of Company
- debt and liquidity details:
Total Debt to Capital InterCure Ltd.|INCR - Long-Term Debt to Capital|Short-Term Debt to Equity Canndoc|INCR - Aggregate Debt Obligations|Debt to Book Capitalization Ratio InterCure Ltd.|INCR - Company Long-Term Liabilities|Company Short-Term Debts InterCure|Quick Liquidity intercure.co
- earnings and valuation multiples indicators:
INCR - Company Profit
General company analysis:INCR - intercure.co
Manufactured products of Canndoc

Short-term debts measure a business's liquid margin of safety, determining its ability to settle obligations with a horizon of up to one year without the risk of default. By analyzing the current level of short-term debt, an investor assesses the financial stability of InterCure Ltd. (INCR) during a period of aggressive expansion of its European pharmacy network and medical cannabis distribution, where the balance of borrowings critically impacts the pace of global expansion.

Competitor analysis

Indivior - Company Short-Term Debts|Collegium Pharma (COLL) - Company Current Liabilities|Cronos (CRON) - Company Short-Term Debt|Short-Term Debt Canopy Growth Corp. (CGC)|Company Current Liabilities HITI|ACB: Company Short-Term Loans and Borrowings|Company Short-Term Debts ACHV|SKYE: Current Liabilities|Company Short-Term Debts ANEB (Anebulo)|Company Short-Term Debts Nutriband Inc NTRB|NSRX - Company Short-Term Debt|Company Short-Term Loans and Borrowings IGC (IGC Pharma, Inc.)|mirapharmaceuticals.com (MIRA) - Company Short-Term Debt|Company Current Liabilities Flora Growth Corp|IMCC (IM Cannabis Corp) - Company Short-Term Debts|Adial (ADIL) - Short-Term Debt Volume|Company Short-Term Debt Artelo Biosciences (ARTL)|ensysce.com - Company Short-Term Indebtedness|Titan Pharmaceuticals, Inc. - Company Current Liabilities|Amount of Current Liabilities GNLN (Greenlane Holdings, Inc.)|InMed Pharma - Company Short-Term Debts|Short-Term Debt Akanda Inc|Enveric Biosciences (ENVB) - Company Short-Term Debt|Bright Green Corporation - Company Short-Term Loans and Borrowings|HPCO (Hempacco) - Company Short-Term Debts